In past blogs, we’ve talked about things our community can do to help advance research and improve treatments for patients facing the challenge of colorectal cancer, including asking Senators to pass the 21st Century Cures Act and supporting the Administration’s Moon Shot initiative. But there is a vital element of advancing research that is outside the control of the scientists who conduct the work and the entities that fund it: clinical trials—the link between scientific discovery and new treatments for colorectal cancer.
On May 25, 1961, President Kennedy told Congress his administration was committed to putting a man on the moon by the end of the decade. The human effort this would require dwarfed virtually every initiative attempted before then, and only the construction of the Panama Canal and Manhattan Project would cost more. In 1961, the world lacked the technology to achieve a lunar landing; but through research, innovation and an unwavering commitment to the goal, on July 21, 1969, Neil Armstrong planted the Stars and Stripes on the moon.
Last month, President Obama tasked Vice President Biden to lead a new lunar mission that, if successful, would benefit humankind in ways far beyond space exploration. Themed “the Moonshot,” it is a new national initiative to work toward a cure for cancer and includes plans to funnel $1 billion into the project. Obama’s mission to “make America the country that cures cancer once and for all” is one all Americans should embrace. One out of every two men and one out of every three women will get cancer in their lifetime. Every single day 1,600 Americans die from cancer and colon cancer is the second leading cause of these deaths.